Filing Details
- Accession Number:
- 0001179110-19-013164
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-27 17:00:08
- Reporting Period:
- 2019-12-24
- Accepted Time:
- 2019-12-27 17:00:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1235010 | Momenta Pharmaceuticals Inc | MNTA | Biological Products, (No Disgnostic Substances) (2836) | 043561634 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1755118 | Ian Fier | C/O Momenta Pharmaceuticals, Inc. 301 Binney Street Cambridge MA 02142 | Chief Mfg And Program Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-12-24 | 35,437 | $10.83 | 40,315 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-12-24 | 39,133 | $20.00 | 1,182 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2019-12-24 | 6,398 | $0.00 | 6,398 | $10.83 |
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2019-12-24 | 29,039 | $0.00 | 29,039 | $10.83 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 2,363 | 2019-11-09 | 2026-02-09 | No | 4 | M | Direct |
| 0 | 2019-11-09 | 2026-02-09 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan.
Billionaire Hedge Funds
